全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

血清铁蛋白在成人急性髓系白血病治疗中的研究进展
Research Progress of Serum Ferritin in the Treatment of Adult Acute Myeloid Leukemia

DOI: 10.12677/ACM.2023.133492, PP. 3450-3456

Keywords: 急性髓系白血病,血清铁蛋白,治疗
Acute Myeloid Leukemia
, Serum Ferritin, Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

血清铁蛋白是一种去铁蛋白和铁核心形成的复合物,除作为储存铁外,血清铁蛋白还被作为一种癌症标志,血清铁蛋白通过铁依赖或非铁依赖的方式参与多种生物学过程,较高水平的血清铁蛋白能够促进急性髓系白血病的发生、发展和化疗耐药等过程。并且高血清铁蛋白在AML患者中是独立以及常见的导致不良预后的因素。因此,关于血清铁蛋白导致AML不良预后的研究,有希望为高血清铁蛋白的AML患者的治疗提供更为有针对性的选择方案。本文就血清铁蛋白在AML治疗中的研究进展作一综述。
Serum ferritin is a complex formed by ferritin and iron core. In addition to storing iron, serum ferri-tin is also used as a cancer marker. Serum ferritin participates in a variety of biological processes in an iron-dependent or non-iron-dependent manner. Higher levels of serum ferritin can promote the occurrence, development and chemoresistance of acute myeloid leukemia. And high serum ferritin is an independent and common factor leading to poor prognosis in AML patients. Therefore, the study on the adverse prognosis of AML caused by serum ferritin is hopeful to provide more targeted options for the treatment of AML patients with high serum ferritin. This article reviews the research progress of serum ferritin in the treatment of AML.

References

[1]  Bebeshko, V.G., Bruslova, K.M., Lyashenko, L.O., et al. (2020) Prognosis of Acute Leukemia Depending on the Iron Metabolism Parameters in Children after Chornobyl Nuclear Power Plant Accident. Problemy Radiatsiinoi Medytsyny ta Radiobiolohii, 25, 390-401.
[2]  Du, J., Wang, T., Li, Y., et al. (2019) DHA Inhibits Proliferation and Induces Ferroptosis of Leukemia Cells through Autophagy Dependent Degradation of Ferritin. Free Radical Biology & Medicine, 131, 356-369.
https://doi.org/10.1016/j.freeradbiomed.2018.12.011
[3]  Ihlow, J., Gross, S., Sick, A., et al. (2019) AML: High Serum Ferritin at Initial Diag-nosis Has a Negative Impact on Long-Term Survival. Leukemia & Lymphoma, 60, 69-77.
https://doi.org/10.1080/10428194.2018.1461860
[4]  Lebon, D., Vergez, F., Bertoli, S., et al. (2015) Hyperfer-ritinemia at Diagnosis Predicts Relapse and Overall Survival in Younger AML Patients with Intermediate-Risk Cytoge-netics. Leukemia Research, 39, 818-821.
https://doi.org/10.1016/j.leukres.2015.05.001
[5]  Alkhateeb, A.A. and Connor, J.R. (2010) Nuclear Ferritin: A New Role for Ferritin in Cell Biology. Biochimica et Biophysica Acta, 1800, 793-797.
https://doi.org/10.1016/j.bbagen.2010.03.017
[6]  Bertoli, S., Paubelle, E., Bérard, E., et al. (2019) Ferritin Heavy/Light Chain (FTH1/FTL) Expression, Serum Ferritin Levels, and Their Functional as Well as Prognostic Roles in Acute Myeloid Leukemia. European Journal of Haematology, 102, 131-142.
https://doi.org/10.1111/ejh.13183
[7]  Buranrat, B. and Connor, J.R. (2015) Cytoprotective Effects of Ferritin on Doxorubicin-Induced Breast Cancer Cell Death. Oncology Reports, 34, 2790-2796.
https://doi.org/10.3892/or.2015.4250
[8]  Canzoneri, J.C. and Oyelere, A.K. (2008) Interaction of Anthracyclines with Iron Responsive Element mRNAs. Nucleic Acids Research, 36, 6825-6834.
https://doi.org/10.1093/nar/gkn774
[9]  Chan, L.S.A., Gu, L.C. and Wells, R.A. (2021) The Effects of Secondary Iron Overload and Iron Chelation on a Radiation-Induced Acute Myeloid Leukemia Mouse Model. BMC Cancer, 21, 509.
https://doi.org/10.1186/s12885-021-08259-9
[10]  黄贵清, 廖清奎, 罗春华. 急性白血病患儿外周血白血病细胞TfR表达与细胞增殖力和铁代谢的关系[J]. 中华血液学杂志, 1999(3): 134.
[11]  Tachibana, T. andou, T., Tanaka, M., et al. (2018) Clinical Significance of Serum Ferritin at Diagnosis in Patients with Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study. Clinical Lymphoma, Myeloma & Leukemia, 18, 415-421.
https://doi.org/10.1016/j.clml.2018.03.009
[12]  Tachibana, T., Tanaka, M., Takasaki, H., et al. (2011) Pretransplant Serum Ferritin Is Associated with Bloodstream Infections within 100 Days of Allogeneic Stem Cell Transplantation for Myeloid Malignancies. International Journal of Hematology, 93, 368-374.
https://doi.org/10.1007/s12185-011-0784-0
[13]  Wermke, M., Eckoldt, J., G?tze, K.S., et al. (2018) Enhanced La-bile Plasma Iron and Outcome in Acute Myeloid Leukaemia and Myelodysplastic Syndrome after Allogeneic Haemopoi-etic Cell Transplantation (ALLIVE): A Prospective, Multicentre, Observational Trial. The Lancet Haematology, 5, e201-e210.
https://doi.org/10.1016/S2352-3026(18)30036-X
[14]  Artz, A.S., Logan, B., Zhu, X., et al. (2016) The Prognostic Value of Serum C-Reactive Protein, Ferritin, and Albumin Prior to Allogeneic Transplantation for Acute Myeloid Leu-kemia and Myelodysplastic Syndromes. Haematologica, 101, 1426-1433.
https://doi.org/10.3324/haematol.2016.145847
[15]  Alva, L.C., Bacher, U., Seipel, K., et al. (2018) Iron Overload Is Correlated with Impaired Autologous Stem Cell Mobilization and Survival in Acute Myeloid Leukemia. Transfusion, 58, 2365-2373.
https://doi.org/10.1111/trf.14895
[16]  Yang, Y., Tang, Z., An, T., et al. (2019) The Impact of Iron Chelation Therapy on Patients with Lower/Intermediate IPSS MDS and the Prognostic Role of Elevated Serum Ferritin in Patients with MDS and AML: A Meta-Analysis. Medicine, 98, e17406.
https://doi.org/10.1097/MD.0000000000017406
[17]  Kantarjian, H., Kadia, T., DiNardo, C., et al. (2021) Acute Myeloid Leukemia: Current Progress and Future Directions. Blood Cancer Journal, 11, 41.
https://doi.org/10.1038/s41408-021-00425-3
[18]  D?hner, H., Weisdorf, D.J. and Bloomfield, C.D. (2015) Acute Myeloid Leukemia. The New England Journal of Medicine, 373, 1136-1152.
https://doi.org/10.1056/NEJMra1406184
[19]  Zhu, S., Liu, J., Kang, R., et al. (2021) Targeting NF-κB-Dependent Alkaliptosis for the Treatment of Venetoclax-Resistant Acute Myeloid Leukemia Cells. Biochemical and Biophysical Re-search Communications, 562, 55-61.
https://doi.org/10.1016/j.bbrc.2021.05.049
[20]  Shao, R., Wang, H., Liu, W., et al. (2021) Establishment of a Prognostic Ferroptosis-Related Gene Profile in Acute Myeloid Leukaemia. Journal of Cellular and Molecular Medicine, 25, 10950-10960.
https://doi.org/10.1111/jcmm.17013
[21]  Park, J.M., Mau, C.Z., Chen, Y.C., et al. (2021) A Case-Control Study in Taiwanese Cohort and Meta-Analysis of Serum Ferritin in Pancreatic Cancer. Scientific Reports, 11, Article No. 21242.
https://doi.org/10.1038/s41598-021-00650-7
[22]  Greenberg, P.L., Attar, E., Bennett, J.M., et al. (2011) NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic Syndromes. Journal of the National Comprehensive Cancer Network: JNCCN, 9, 30-56.
[23]  贾国存, 高举, 廖清奎, 等. 白血病细胞可变铁池的检测及其意义[J]. 中国实验血液学杂志, 2006(3): 468-470.
[24]  Estrov, Z., Tawa, A., Wang, X.H., et al. (1987) In Vitro and in Vivo Effects of Deferoxamine in Neonatal Acute Leukemia. Blood, 69, 757-761.
https://doi.org/10.1182/blood.V69.3.757.757
[25]  Cho, B.S., Jeon, Y.W., Hahn, A.R., et al. (2019) Improved Sur-vival Outcomes and Restoration of Graft-vs-Leukemia Effect by Deferasirox after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia. Cancer Medicine, 8, 501-514.
https://doi.org/10.1002/cam4.1928
[26]  Serpell, B.G., Freeman, S., Ritchie, D., et al. (2020) Altitude Exposure as a Training & Iron Overload Management Strategy Post Leu-kemia. Journal of Science and Medicine in Sport, 23, 75-81.
https://doi.org/10.1016/j.jsams.2019.08.292
[27]  Torti, S.V. and Torti, F.M. (2013) Iron and Cancer: More Ore to Be Mined. Nature Reviews Cancer, 13, 342-355.
https://doi.org/10.1038/nrc3495
[28]  Le, N.T. and Richardson, D.R. (2004) Iron Chelators with High Antiprolifer-ative Activity Up-Regulate the Expression of a Growth Inhibitory and Metastasis Suppressor Gene: A Link between Iron Metabolism and Proliferation. Blood, 104, 2967-2975.
https://doi.org/10.1182/blood-2004-05-1866
[29]  Birsen, R., Larrue, C., Decroocq, J., et al. (2022) APR-246 Induces Early Cell Death by Ferroptosis in Acute Myeloid Leukemia. Haematologica, 107, 403-416.
https://doi.org/10.3324/haematol.2020.259531
[30]  Jiang, X., Stockwell, B.R. and Conrad, M. (2021) Ferroptosis: Mechanisms, Biology and Role in Disease. Nature Reviews Molecular Cell Biology, 22, 266-282.
https://doi.org/10.1038/s41580-020-00324-8
[31]  Luo, L., Wang, H., Tian, W., et al. (2021) Targeting Ferroptosis for Cancer Therapy: Iron Metabolism and Anticancer Immunity. American Journal of Cancer Research, 11, 5508-5525.
https://doi.org/10.7150/thno.65480
[32]  Grignano, E., Birsen, R., Chapuis, N., et al. (2020) From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells. Frontiers in Oncology, 10, Ar-ticle ID: 586530.
https://doi.org/10.3389/fonc.2020.586530
[33]  Du, Y., Bao, J., Zhang, M.J., et al. (2020) Targeting Ferroptosis Contributes to ATPR-Induced AML Differentiation via ROS-Autophagy-Lysosomal Pathway. Gene, 755, Article ID: 144889.
https://doi.org/10.1016/j.gene.2020.144889
[34]  Wang, M.P., Joshua, B., Jin, N.Y., et al. (2022) Ferrop-tosis in Viral Infection: The Unexplored Possibility. Acta Pharmacologica Sinica, 43, 1905-1915.
[35]  Olcay, L., Hazirolan, T., Yildirmak, Y., et al. (2014) Biochemical, Radiologic, Ultrastructural, and Genetic Evaluation of Iron Overload in Acute Leukemia and Iron-Chelation Therapy. Journal of Pediatric Hematology/Oncology, 36, 281-292.
https://doi.org/10.1097/MPH.0b013e3182a11698
[36]  Knovich, M.A., Storey, J.A., Coffman, L.G., et al. (2009) Ferritin for the Clinician. Blood Reviews, 23, 95-104.
https://doi.org/10.1016/j.blre.2008.08.001
[37]  Wenzel, S.E., Tyurina, Y.Y., Zhao, J., et al. (2017) PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell, 171, 628-641.e26.
https://doi.org/10.1016/j.cell.2017.09.044
[38]  Yusuf, R.Z., Saez, B., Sharda, A., et al. (2020) Aldehyde Dehydro-genase 3a2 Protects AML Cells from Oxidative Death and the Synthetic Lethality of Ferroptosis Inducers. Blood, 136, 1303-1316.
https://doi.org/10.1182/blood.2019001808
[39]  Dong, L.H., Huang, J.J., Zu, P., et al. (2021) CircKDM4C Upreg-ulates P53 by Sponging Hsa-let-7b-5p to Induce Ferroptosis in Acute Myeloid Leukemia. Environmental Toxicology, 36, 1288-1302.
https://doi.org/10.1002/tox.23126
[40]  Li, M., Chen, X., Wang, X., et al. (2021) RSL3 Enhances the Antitumor Effect of Cisplatin on Prostate Cancer Cells via Causing Glycolysis Dysfunction. Biochemical Pharmacology, 192, Article ID: 114741.
https://doi.org/10.1016/j.bcp.2021.114741
[41]  Zhu, H.Y., Huang, Z.X., Chen, G.Q., et al. (2019) Typhaneoside Prevents Acute Myeloid Leukemia (AML) through Suppressing Proliferation and Inducing Ferroptosis Associated with Autophagy. Biochemical and Biophysical Research Communications, 516, 1265-1271.
https://doi.org/10.1016/j.bbrc.2019.06.070
[42]  Liu, S., Cao, X., Wang, D., et al. (2022) Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology. Archives of Biochemistry and Biophysics, 723, Article ID: 109199.
https://doi.org/10.1016/j.abb.2022.109199

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133